Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients
Ilies Benotmane, Aurélie Velay, Gabriela Gautier Vargas, Jérôme Olagne, Samira Fafi-Kremer, Olivier Thaunat, View ORCID ProfileSophie Caillard
doi: https://doi.org/10.1101/2022.03.19.22272575
Ilies Benotmane
1Department of Nephrology and Transplantation, Strasbourg University Hospital, 67000 Strasbourg, France
MDAurélie Velay
2Department of Virology, Strasbourg University Hospital, 67000 Strasbourg, France
PharmD PhDGabriela Gautier Vargas
1Department of Nephrology and Transplantation, Strasbourg University Hospital, 67000 Strasbourg, France
MDJérôme Olagne
1Department of Nephrology and Transplantation, Strasbourg University Hospital, 67000 Strasbourg, France
MDSamira Fafi-Kremer
2Department of Virology, Strasbourg University Hospital, 67000 Strasbourg, France
PharmD PhDOlivier Thaunat
3Hospices Civils de Lyon, Edouard Herriot Hospital, Department of Transplantation, Nephrology and Clinical Immunology, 5, place d’Arsonval, 69003 Lyon, France
MD PhDSophie Caillard
1Department of Nephrology and Transplantation, Strasbourg University Hospital, 67000 Strasbourg, France
MD PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted March 19, 2022.
Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients
Ilies Benotmane, Aurélie Velay, Gabriela Gautier Vargas, Jérôme Olagne, Samira Fafi-Kremer, Olivier Thaunat, Sophie Caillard
medRxiv 2022.03.19.22272575; doi: https://doi.org/10.1101/2022.03.19.22272575
Breakthrough Covid-19 cases despite tixagevimab and cilgavimab (Evusheld™) prophylaxis in kidney transplant recipients
Ilies Benotmane, Aurélie Velay, Gabriela Gautier Vargas, Jérôme Olagne, Samira Fafi-Kremer, Olivier Thaunat, Sophie Caillard
medRxiv 2022.03.19.22272575; doi: https://doi.org/10.1101/2022.03.19.22272575
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2657)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12254)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4116)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2666)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (854)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3899)
- Nursing (210)
- Nutrition (579)
- Oncology (2038)
- Ophthalmology (586)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6542)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (185)
- Urology (166)